Vaccines

Discovery & Development Formulation

03/20/2023 | Joseph Payne | 8 min read

Why is self-amplifying mRNA gaining more and more attention in the vaccine space?

Manufacture Vaccines

03/16/2023 | Stephanie Vine | 7 min read

Universal flu vaccines have been the holy grail for many years – are we onto a breakthrough at last?

Business & Regulation Business Practice

03/06/2023 | Rainer Lichtenberger | 8 min read

What are the lessons we must learn from the COVID-19 pandemic?

Manufacture Facilities

01/24/2023 | Angus Stewart | 6 min read

New technologies offer cheaper modes of manufacture – here’s how and why the world’s less wealthy countries could seize the moment.

Business & Regulation COVID-19

01/18/2023 | Stephanie Vine | 3 min read

Anti-vaccine activists are suing a number of prominent media outlets, including Reuters, the Washington Post, the BBC, and the Associated Press.

Business & Regulation Profession

01/05/2023 | Angus Stewart | 3 min read

The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions

Manufacture Vaccines

12/16/2022 | Angus Stewart | 8 min read

From hemispheric analysis to hatchery logistics, there’s a lot more to vaccine production than you might suspect

Manufacture Vaccines

12/01/2022 | Sponsored by Thermo Fisher Scientific | 8 min read

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Discovery & Development Formulation

11/18/2022 | Stephanie Vine | 2 min read

Could dry vaccines help improve global access to the latest vaccine technologies?

Manufacture Vaccines

09/09/2022 | Pirkko Muhonen, Sirat Sikka | 6 min read

Exploring the potential of self-amplifying RNA and circular RNA in the future of drug development.